News

Professional Development Efficaciousness of mental health outreach in religious settings Conference (Presenter, 2010) Sponsor: Association of Academic Psychiatry’s Annual Meeting Gupta V, Shah AA, ...
After experiencing catastrophic storms from near and far, anxiety might creep up when you hear about the next weather event.
Positions Professor & Alice R. McPherson Retina Research Foundation Chair in Ophthalmology Baylor College of Medicine Staff Physician/Professor Ben Taub General Hospital Addresses Jamail Specialty ...
Following the tragic July 4 floods in Texas, children might feel their grief set in as they return to school. Some will ...
Six Baylor College of Medicine faculty were honored this year with the Michael E. DeBakey M.D. Award for Excellence in Research for their outstanding published scientific contributions to clinical and ...
Dehydration occurs when your body doesn’t have enough fluids to function effectively. Dr. Sara Andrabi explains the symptoms of dehydration and who is ...
With the summer months arriving, some situations may cause changes to your sleep schedule. Dr. Philip Alapat, a sleep expert and associate professor of medicine in the pulmonary, critical care and ...
While Alzheimer’s disease is mostly considered a disorder of the brain, emerging evidence suggests that the condition also affects other organs of the body. Working with the laboratory fruit fly, ...
Baylor College of Medicine was recognized as a top institution for medical research, earning Tier 1 status in the U.S. News & World Report 2025 Best Graduate Schools rankings. Baylor is one of only 16 ...
Baylor College of Medicine's Center for Educational Outreach has entered into an agreement with the Midland Independent School District (MISD) to create a district-wide STEM+M (science, technology, ...
Motion sickness is a very common condition that affects about 1 in 3 people, but the brain circuits involved are largely unknown. In the current study published in Nature Metabolism, researchers at ...
A new study published in the journal Nature reports results of the first-in-human phase 1 clinical trials of a novel immunotherapy approach for solid tumors ...